The trajectory of Viagra presents a complex picture for investors. While the initial release generated significant gains, the lapse of its intellectual property protection opened the door to off-brand competitors, dramatically reducing market share. This creates a unique challenge for drug manufacturers relying on similar blockbuster products, sugg

The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in sales , its patent expiration created a wave of lower-priced alternatives , significantly diminishing its position . While some businesses may attempt to capitalize on similar conditions , the exi